🇺🇸 FDA
Patent

US 11028128

Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments

granted A61KA61K38/00

Quick answer

US patent 11028128 (Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments) held by The Regents of the University of California expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00